Polymer conjugation to the Feldan Shuttle and its cargo to increase bioavailability in circulation
聚合物与 Feldan Shuttle 及其货物的结合可提高循环中的生物利用度
基本信息
- 批准号:530982-2018
- 负责人:
- 金额:$ 0.91万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Engage Plus Grants Program
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
For a medication to be effective, it must be able to reach its target. One of the greatest challenges for many**drugs is that their targets lie inside cells. Indeed, cells are surrounded by a membrane that keeps many**molecules out - including drugs. Even the most powerful drug will be ineffective if it cannot reach its target.**Feldan Therapeutics Inc. has developed a technology, termed the Feldan Shuttle, which facilitates the transfer**of several types of drugs into cells. They now face a technological challenge, associated with the ability of the**Shuttle to be effective in the context of intravenous injections, that they cannot resolve themselves. As such,**Feldan Therapeutics Inc. has approached Prof Marc A Gauthier of the INRS to investigate structural alterations**to the Shuttle and its cargo to increase their bioavailability in circulation.
要使药物有效,它必须能够达到其目标。许多药物面临的最大挑战之一是它们的靶点位于细胞内。事实上,细胞被一层膜所包围,这层膜将许多 ** 分子(包括药物)拒之门外。即使是最强大的药物,如果不能达到目标,也会无效。费尔丹治疗公司已经开发了一种技术,称为费尔丹穿梭机,它有助于将几种类型的药物转移到细胞中。他们现在面临着一个技术挑战,与 ** 航天飞机在静脉注射方面的有效能力有关,他们无法自己解决。因此,**Feldan Therapeutics Inc.已经与INRS的Marc A Gauthier教授接触,研究航天飞机及其货物的结构改变 **,以增加其在循环中的生物利用度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gauthier, Marc其他文献
Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype
- DOI:
10.1016/j.jaci.2020.05.051 - 发表时间:
2020-08-01 - 期刊:
- 影响因子:14.2
- 作者:
Camiolo, Matthew;Gauthier, Marc;Wenzel, Sally E. - 通讯作者:
Wenzel, Sally E.
Evolving Concepts of Asthma
- DOI:
10.1164/rccm.201504-0763pp - 发表时间:
2015-09-15 - 期刊:
- 影响因子:24.7
- 作者:
Gauthier, Marc;Ray, Anuradha;Wenzel, Sally E. - 通讯作者:
Wenzel, Sally E.
Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias
- DOI:
10.1172/jci.insight.94580 - 发表时间:
2017-07-06 - 期刊:
- 影响因子:8
- 作者:
Gauthier, Marc;Chakraborty, Krishnendu;Ray, Anuradha - 通讯作者:
Ray, Anuradha
Gauthier, Marc的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gauthier, Marc', 18)}}的其他基金
A platform for engineering bi-specific antibody constructs
用于工程化双特异性抗体构建体的平台
- 批准号:
RGPIN-2021-03301 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
A platform for engineering bi-specific antibody constructs
用于工程化双特异性抗体构建体的平台
- 批准号:
RGPIN-2021-03301 - 财政年份:2021
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Bioconjugate approaches for the systemic delivery of proteins with the Feldan Shuttle
使用 Feldan Shuttle 系统输送蛋白质的生物共轭方法
- 批准号:
536874-2018 - 财政年份:2020
- 资助金额:
$ 0.91万 - 项目类别:
Collaborative Research and Development Grants
"Click ON/OFF" chemistry via sulfonium-activated groups
通过锍激活基团进行“点击开/关”化学反应
- 批准号:
RGPIN-2015-04254 - 财政年份:2019
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Bioconjugate approaches for the systemic delivery of proteins with the Feldan Shuttle
使用 Feldan Shuttle 系统输送蛋白质的生物共轭方法
- 批准号:
536874-2018 - 财政年份:2019
- 资助金额:
$ 0.91万 - 项目类别:
Collaborative Research and Development Grants
Addressing an immediate manufacturing need of the therapeutic antibody industry - reduce viscosity to reduce cost.
满足治疗性抗体行业的迫切生产需求 - 降低粘度以降低成本。
- 批准号:
493874-2016 - 财政年份:2018
- 资助金额:
$ 0.91万 - 项目类别:
Strategic Projects - Group
"Click ON/OFF" chemistry via sulfonium-activated groups
通过锍激活基团进行“点击开/关”化学反应
- 批准号:
RGPIN-2015-04254 - 财政年份:2018
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Polymer conjugation to the Feldan Shuttle to reduce blood protein adsorption and interaction with cell membranes
聚合物与 Feldan Shuttle 结合,减少血液蛋白吸附以及与细胞膜的相互作用
- 批准号:
521307-2017 - 财政年份:2017
- 资助金额:
$ 0.91万 - 项目类别:
Engage Grants Program
“Click ON/OFF” chemistry via sulfonium-activated groups
– 通过锍激活基团点击“开/关”化学反应
- 批准号:
RGPIN-2015-04254 - 财政年份:2017
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Smart polymer for antibody purification
用于抗体纯化的智能聚合物
- 批准号:
493244-2015 - 财政年份:2017
- 资助金额:
$ 0.91万 - 项目类别:
Collaborative Research and Development Grants
相似海外基金
RUI: New Porphyrinoid Architectures with Extended Conjugation Pathways
RUI:具有扩展共轭途径的新型卟啉结构
- 批准号:
2247214 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Standard Grant
Conjugation and encapsulation of photoactive metal complexes for medicinal applications
用于医学应用的光敏金属配合物的缀合和封装
- 批准号:
2784635 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Studentship
Multiplexed in vivo assembly of long and complex DNA
长且复杂的 DNA 的多重体内组装
- 批准号:
10760876 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Development of "humanized" molecule-molecule conjugation module proteins by protein engineering
通过蛋白质工程开发“人源化”分子-分子缀合模块蛋白质
- 批准号:
23K19239 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
RII Track-4:NSF: Bioactive Surfaces Through Affinity Tag Protein-Polymer Conjugation
RII Track-4:NSF:通过亲和标签蛋白-聚合物缀合形成生物活性表面
- 批准号:
2229274 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Standard Grant
Criation of topological pi-conjugation system
拓扑π共轭系统的提出
- 批准号:
22H02068 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Circadian Regulation of Antibiotic Resistance in the Microbiome
微生物组抗生素耐药性的昼夜节律调节
- 批准号:
10465012 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Enzyme-Mediated Site-Specific Conjugation of Antibodies to Nanoparticles
酶介导的抗体与纳米颗粒的位点特异性缀合
- 批准号:
10436681 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Mitigating ADA Through Site-specific Conjugation Technology
通过位点特异性缀合技术缓解 ADA
- 批准号:
10750703 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Innovations in protein-lipid conjugation and novel technologies for developing protein-based nanodelivery systems to improve the delivery mechanism, efficacy, and bioavailability of bioactives
蛋白质-脂质结合的创新和开发基于蛋白质的纳米递送系统的新技术,以改善生物活性物质的递送机制、功效和生物利用度
- 批准号:
RGPIN-2020-07136 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual